Production (Stage)
Artelo Biosciences, Inc.
ARTL
$0.9527
-$0.0023-0.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.16% | -5.78% | 4.54% | -10.62% | 6.63% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 123.21% | 35.80% | -45.77% | -72.20% | -84.41% |
| Change in Net Operating Assets | 490.80% | 36.80% | -64.66% | 110.06% | 31.32% |
| Cash from Operations | 21.85% | -1.74% | -6.01% | -20.58% | -10.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 152.23% | 121.53% | 290.71% | 198.93% | -47.41% |
| Cash from Investing | 152.23% | 121.53% | 290.71% | 198.93% | -47.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.84% | -80.25% | -83.74% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.84% | -80.25% | -87.00% | 364.18% | -- |
| Foreign Exchange rate Adjustments | -102.33% | -113.33% | -100.00% | 128.30% | 122.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.15% | 88.29% | 138.20% | 24.44% | -66.60% |